Logo

Abbott Launches Amplatzer Talisman PFO Occlusion System for the Treatment of Patent Foramen Ovale in the EU

Share this
Abbott Launches Amplatzer Talisman PFO Occlusion System for the Treatment of Patent Foramen Ovale in the EU

Abbott Launches Amplatzer Talisman PFO Occlusion System for the Treatment of Patent Foramen Ovale in the EU

Shots:

  • The company launched the Amplatzer Talisman PFO occlusion system for people with patent foramen ovale (PFO) who have had a stroke and are at risk of having another
  • Abbott's Talisman system, a minimally invasive, catheter-based procedure helps to seal an opening in the heart to reduce the risk of another stroke & prevent blood clots from passing from the right to the left side of the heart and onto the brain
  • The Talisman system builds on the Amplatzer PFO Occluder that is pre-attached to the delivery cable. This design reduces preparation time for doctors and increases ease of use. The Talisman device is also fully recapturable and repositionable for easy adjustments and accurate placement

Ref: Abbott | Image: Abbott

Click here to­ read the full press release 

Neha

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions